Studies in Human Sterility with Special Reference To

Total Page:16

File Type:pdf, Size:1020Kb

Studies in Human Sterility with Special Reference To STUDIES IN HUMAN STERILITY WITH SPECIAL REFERENCE TO THE INVEST IGAT ION OP THE PATENCY AND FUNCTION OP THE FALLOPIAN TUBES AND OP THE CONDITION OP THE ENLOMETRIUM. ProQuest Number: 13849840 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 13849840 Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 PREFACE. The thesis which is presented here, consists of two parts &nd an appendix. Part I concerns the pathogenesis, diagnosis and treatment of Human Sterility and is an endeavour to give a comprehensive account of this subject, incorporating a study of much new knowledge and of recent advances which mainly concern technical refinements in the investigation of tubal patency and function, the endometrial cycle and the tfsex hormones.” Only slight reference is made to the male aspect of the problem. In effect, this part of the thesis is almost entirely my contribution to the book ”Sterility and Impaired Fertility” (1959), Hamish Hamilton Medical Books, London, (jointly with C. Lane-Roberts, K. Walker and B.P. Wiesner). The few pages which are included here and which were not written by me are indicated in the text. The essential features of important researches, published since 1959, have been added. Part II concerns the results of a detailed study of 500 Gases of "Sterility,” with particular reference to (1) the functional condition of the Fallopian/ fallopian tubes and (2) the uterine endometrium, .normal and abnormal. These cases comprise an unselected series of patients who had never con­ ceived and who complained primarily of the infertility of their marriage and who were under my observation in the Royal Samaritan Hospital for Women, Glasgow, within the period - July 1953 until February 1943. I am responsible entirely for Part II, which has not as yet been published, although portions of it formed the substance of a paper read at the Annual Meeting of the British Medical Association in 1933. The appendix, concerns the results of original, unpublished researches in cases other than the series above-mentioned. It involves the most recent work, almost entirely done during the years 1941 and 1942. I am greatly indebted to Dr. John Hewitt, not only for facilities in his wards since 1933, but also for his co-operation and encouragement; to Dr. E.B. Morton from 1937 to 1939,and to Dr. D. McIntyre, since 1939, for similar facilities; to the Governors of the Royal Samaritan Hospital fdr Women for providing a Gordon King Kymographic apparatus (the first made in this country); to the British Medical Association for a Research Scholarship at the commencement of this work; and to Dr. I.C. Rubin of New York and Dr. L. Bonnet of Paris for facilities and instruction during visits to their clinics. CONTENTS. P r e f a c e ...... ............................. List of Illustrations ..................... PART I. Page General Survey of the P r o b l e m .......... ' 1 Stages in Investigation ................ 18 Investigation of Specific Functions .... 47 S u m m a r y .......................... 126 Treatment ........ 131 PART II. Introduction........................... 198 Analysis of the Tubal Status ........... 200 Endometrial Biopsy ..................... 231 Examination of the Husband ............. 253 Treatment ............ .258 Results of Follow-up ......... 266 Summary ................ 273 APPEHDIX................. 276 BIBLIOGRAPHY.............. 298 LIST OF ILLUSTRATIONS. Fig. at Page 1 Endometrium removed three d$sys after conclusion of a period ... ... 36 2. Endometrium removed two days before menstruation ............ 36 3 Occurrence of ovulation in menstrual cycle ... ... ... ... ... 39 4 Biopsy specimens of endometrium in three cases of sterility showing characteristics of anovulation 53 5 Siharman & Sheehan’s biopsy curette 57 6 Differing appearances of some endometrium removed a few hours before menstruation ....... 60 7 Specimens of endometrium removed by biopsy curette and by ordinary curette a few minutes later ... 62 ;8 Endometrium removed in premenstrual phase, apparently anovular ... 63 9 Same case as in Fig. 8. Endometrium removed one month later in pre­ menstrual phase showing normal features ...................... 63 10 Bonnet’s apparatus for kymographic insufflation...... ............. 77 11 Rubin’s apparatus for utero-tubal insufflation ..... ........ 79 12 (Jordon Kingte apparatus for utero­ tubal insufflation ....... 80. 13 Gordon King’s apparatus in use 83 14 Kymographic tracing in tubal occlusion .................. 86 Fig. at Page 15 Kymographic tracing in normal tubal patency ... 86 16 Kymographic tracing in normal tubal patency, showing con­ tractions of gareaf amplitude 86 17 Kymographic tracing showing contractions of low frequency and amplitude ... ... 86 18 Kymographic tracing in tubal spasm 90 19 Kymographic tracing in tubal stenosis ............ 90 20 Salpingo graphs showing normal bilateral patency ....... 97 21 Salpingographs showing right isthmial occlusion and left tubal patency ... 97 22 Salpingographs showing bilateral patency in abnormal tubes 97 23 A. Salpingograph showing hydro­ salpinx of left tube with incomplete block ... 98 B. Showing salpingitis with pelvic peritonitis............ 98 24 A. Salpingograph four days before period due ... ... ... 93 B. Same case four days after cessation of period ... 98 25 Salpingograph showing uterine fibroids and dilated tubes occluded at fimbrial ends 98 26 A. Salpingograph showing tubes stretched round fibroid at fundus uteri: Both tubes are patent 98 B. Salpingograph showing isthmial block after tuberculous peri­ tonitis ... 93 at Page 27 Section of endometrium showing incomplete differentiation 102 28 Kymographic tracing from a case in which pressure of gas was raised to 250 mm. Hg. 174 29 Salpingostomy. Formation of circumcision cuff ...... 180 50 Salpingostomy. Preparation for tubo-uterine implantation 180 51 Salpingostomy. Completion of tubo-uterine implantation 180 52' Bilateral obstruction of the tubes in the region of their distal thirds ... 182 55 Same case as in Fig. 52 after excision of right tube and salpingostomy ... ... 182. 54-51 Representative salpingographs 226 52-55 Salpingographs showing tubal blockage ............ 226 56-61 Salpingographs shwoing tubal patency in cases in which insufflation diowed non-patency 229 62-66 Salpingographs showing tubal blockage in cases in which insufflation showed patency 250 67-81 Salpingographs showing very differing appearances when lipiodol injection was repeated,in seven cases - to illustrate difficulty of interpretation 251 82 Salpingograph showing atypical features but tubal patency: conception occurred within four weeks ............ 251 Fig. at Page 85 Same case as in Fig. 82, but in first weeks of pregnancy ... 251 84 Salpingograph showing bilateral fimbrial block - before salpingostomy ............ 251 85 Same case as in Fig. 84, after salpingostomy ............ - 251 86-90 Salpingographs showing unilateral tubal patency ........ .. 251 91-98 Salpingographs showing altered appearances on repetition of test, but diagnosis not contradicted ....... ... 251 99 Endometrium removed one day before menstruation was due - 50th day of cycle ... ... 254 100 Same case as in Fig. 99, endometrium removed four days later (another four days elapsed before menstruation actually occurred) ...... 254 101-159 Biopsy specimens of endo­ metrium in eleven cases of sterility showing character­ istics of ’periodic1 anovula­ tion ....... 256-259 140-171 Biopsy specimens of endo­ metrium in twelve cases of sterility showing characteristics of (constant{ anovulation 240-244 172-205 Biopsy specimens of endo­ metrium, in twenty cases of sterility, showing tuberculous endometritis 245-253 204 Endometrium removed two days before menstruation after twfifity injections of gonadotropic hormone; same case as Figs. 148-153 262 Fig. at Page 205 Same case as in Fig. 204, endome­ trium removed eight days before a period, after six injections of gonadotropic hormone ... 262 206 Endometrium removed several hours before menstruation after six injections of gonadotropic hormone; same case as Figs. 145-147 ... ............ 265 207 Endometrium removed two days before ’period* due (26th day of cycle) after five injections of oestro­ genic hormone, 50,000 units each: same case as Figs. 122 and 125 265 208 Endometrium removed six days before menstruation after a course of oestrogenic hormone ... 265 209 Same case as in Fig. 209, six days before the succeeding period 265 210 Endometrium removed two days before menstruation, after a single dose of oestrogenic hormone (100,000 units) .................. 264 211 Same case as in Fig. 210, two months later after same treat­ ment : biopsy two days before menstruation .......... 264 212 Same case, endometrium removed during second day of menstruation 264 215 Same case: endometrium removed two days before menstruation after single injection of gonadotropic hormone .................. 264 Plate I-XIII Kymographic tracings of tubal insufflation ............. 208-224
Recommended publications
  • The Leucoplakic Vulva: Premalignant Determinants C
    Henry Ford Hospital Medical Journal Volume 11 | Number 3 Article 3 9-1963 The Leucoplakic Vulva: Premalignant Determinants C. Paul Hodgkinson Roy B. P. Patton M. A. Ayers Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation Hodgkinson, C. Paul; Patton, Roy B. P.; and Ayers, M. A. (1963) "The Leucoplakic Vulva: Premalignant Determinants," Henry Ford Hospital Medical Bulletin : Vol. 11 : No. 3 , 279-287. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol11/iss3/3 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. For more information, please contact [email protected]. Henry Ford Hosp. Med. Bull. Vol. 11, September, 1963 THE LEUCOPLAKIC VULVA Premalignant Determinants C. PAUL HODGKINSON, M.D.,* ROY B. P. PATTON, M.D., AND M. A. AYERS, M.D.* IN A PAPER proposing to discuss the leucoplakic vulva and any predisposing ten­ dency it may have to the development of squamous cell carcinoma, the term "pre­ malignant" has presumptuous connotations. This is presumptuous because it implies that more is known about cancer and its mode of development than can be supported by facts. What happens in the cell prior to the stage of carcinoma-in-situ is a burning and unsolved question in cancer research. How to detect and appraise the parameters of malignant potential is the essence of meaning connoted by the word "premalignant".
    [Show full text]
  • Vaginitis and Abnormal Vaginal Bleeding
    UCSF Family Medicine Board Review 2013 Vaginitis and Abnormal • There are no relevant financial relationships with any commercial Vaginal Bleeding interests to disclose Michael Policar, MD, MPH Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine [email protected] Vulvovaginal Symptoms: CDC 2010: Trichomoniasis Differential Diagnosis Screening and Testing Category Condition • Screening indications – Infections Vaginal trichomoniasis (VT) HIV positive women: annually – Bacterial vaginosis (BV) Consider if “at risk”: new/multiple sex partners, history of STI, inconsistent condom use, sex work, IDU Vulvovaginal candidiasis (VVC) • Newer assays Skin Conditions Fungal vulvitis (candida, tinea) – Rapid antigen test: sensitivity, specificity vs. wet mount Contact dermatitis (irritant, allergic) – Aptima TMA T. vaginalis Analyte Specific Reagent (ASR) Vulvar dermatoses (LS, LP, LSC) • Other testing situations – Vulvar intraepithelial neoplasia (VIN) Suspect trich but NaCl slide neg culture or newer assays – Psychogenic Physiologic, psychogenic Pap with trich confirm if low risk • Consider retesting 3 months after treatment Trichomoniasis: Laboratory Tests CDC 2010: Vaginal Trichomoniasis Treatment Test Sensitivity Specificity Cost Comment Aptima TMA +4 (98%) +3 (98%) $$$ NAAT (like GC/Ct) • Recommended regimen Culture +3 (83%) +4 (100%) $$$ Not in most labs – Metronidazole 2 grams PO single dose Point of care – Tinidazole 2 grams PO single dose •Affirm VP III +3 +4 $$$ DNA probe • Alternative regimen (preferred for HIV infected
    [Show full text]
  • UWOMJ Volume 25, Number 4, November 1955 Western University
    Western University Scholarship@Western University of Western Ontario Medical Journal Digitized Special Collections 11-1955 UWOMJ Volume 25, Number 4, November 1955 Western University Follow this and additional works at: https://ir.lib.uwo.ca/uwomj Part of the Medicine and Health Sciences Commons Recommended Citation Western University, "UWOMJ Volume 25, Number 4, November 1955" (1955). University of Western Ontario Medical Journal. 244. https://ir.lib.uwo.ca/uwomj/244 This Book is brought to you for free and open access by the Digitized Special Collections at Scholarship@Western. It has been accepted for inclusion in University of Western Ontario Medical Journal by an authorized administrator of Scholarship@Western. For more information, please contact [email protected], [email protected]. Office Gynaecology W. Pelton Tew, M.B., F.R.C.S., Edin. & Can., F.R.C.O.G. The term gynaecology means the treat­ Special articles of equipment: This ment of diseases peculiar to the female would include a biopsy punch (sterilized), genitalia, and office gynaecology, of an Ayres spatula for taking cervical course, refers to the management or treat­ smears, a microscope and suitable stains, ment of the diseases peculiar to the fe­ a small incubator is very handy, insufflator male genitalia and these diseases are such for treating trichamona and some special that one is able to properly manage or solutions or powders used for specific to treat them in the office. Besides this, treatments of trichamona and the yeast of course, there are certain diagnostic fungus, an electric cautery for cervical procedures which may be carried out in catarrh cases.
    [Show full text]
  • Female Infertility: Ultrasound and Hysterosalpoingography
    s z Available online at http://www.journalcra.com INTERNATIONAL JOURNAL OF CURRENT RESEARCH International Journal of Current Research Vol. 11, Issue, 01, pp.745-754, January, 2019 DOI: https://doi.org/10.24941/ijcr.34061.01.2019 ISSN: 0975-833X RESEARCH ARTICLE FEMALE INFERTILITY: ULTRASOUND AND HYSTEROSALPOINGOGRAPHY 1*Dr. Muna Mahmood Daood, 2Dr. Khawla Natheer Hameed Al Tawel and 3 Dr. Noor Al _Huda Abd Jarjees 1Radiologist Specialist, Ibin Al Atheer hospital, Mosul, Iraq 2Lecturer Radiologist Specialist, Institue of radiology, Mosul, Iraq 3Radiologist Specialist, Ibin Al Atheer Hospital, Mosu, Iraq ARTICLE INFO ABSTRACT Article History: The causes of female infertility are multifactorial and necessitate comprehensive evaluation including Received 09th October, 2018 physical examination, hormonal testing, and imaging. Given the associated psychological and Received in revised form th financial stress that imaging can cause, infertility patients benefit from a structured and streamlined 26 November, 2018 evaluation. The goal of such a work up is to evaluate the uterus, endometrium, and fallopian tubes for Accepted 04th December, 2018 anomalies or abnormalities potentially preventing normal conception. Published online 31st January, 2019 Key Words: WHO: World Health Organization, HSG, Hysterosalpingography, US: Ultrasound PID: pelvic Inflammatory Disease, IV: Intravenous. OHSS: Ovarian Hyper Stimulation Syndrome. Copyright © 2019, Muna Mahmood Daood et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Citation: Dr. Muna Mahmood Daood, Dr. Khawla Natheer Hameed Al Tawel and Dr. Noor Al _Huda Abd Jarjees. 2019. “Female infertility: ultrasound and hysterosalpoingography”, International Journal of Current Research, 11, (01), 745-754.
    [Show full text]
  • Localised Provoked Vestibulodynia (Vulvodynia): Assessment and Management
    FOCUS Localised provoked vestibulodynia (vulvodynia): assessment and management Helen Henzell, Karen Berzins Background hronic vulvar pain (pain lasting more than 3–6 months, but often years) is common. It is estimated to affect 4–8% of Vulvodynia is a chronic vulvar pain condition. Localised C women at any one time and 10–20% in their lifetime.1–3 provoked vestibulodynia (LPV) is the most common subset Little attention has been paid to the teaching of this condition of vulvodynia, the hallmark symptom being pain on vaginal so medical practitioners may not recognise the symptoms, and penetration. Young women are predominantly affected. LPV diagnosis is often delayed.2 Community awareness is low, but is a hidden condition that often results in distress and shame, increasing with media attention. Women can be confused by the is frequently unrecognised, and women usually see a number symptoms and not know how to discuss vulvar pain. The onus is of health professionals before being diagnosed, which adds to on medical practitioners to enquire about vulvar pain, particularly their distress and confusion. pain with sex, when taking a sexual or reproductive health history. Objective Vulvodynia The aim of this article is to inform health providers about the Vulvodynia is defined by the International Society for the Study assessment and management of LPV. of Vulvovaginal Disease (ISSVD) as ‘chronic vulvar discomfort, most often described as burning pain, occurring in the absence Discussion of relevant findings or a specific, clinically identifiable, neurologic 4 Diagnosis is based on history. Examination is used to support disorder’. It is diagnosed when other causes of vulvar pain have the diagnosis.
    [Show full text]
  • Effect of Educational Program on Vulvitis Prevention Among Nursing Students
    American Journal of Nursing Science 2018; 7(6): 254-267 http://www.sciencepublishinggroup.com/j/ajns doi: 10.11648/j.ajns.20180706.19 ISSN: 2328-5745 (Print); ISSN: 2328-5753 (Online) Effect of Educational Program on Vulvitis Prevention Among Nursing Students Somaya Ouda Abd EL-Menim 1, Huda Abdalla Moursi 2, Ahlam Elahmady Mohamed Sarhan 2 1Obstetric and Woman Health Nursing, Faculty of Nursing, Benha University, Benha, Egypt 2Community Health Nursing, Benha University, Benha, Egypt Email address: To cite this article: Somaya Ouda Abd EL-Menim, Huda Abdalla Moursi, Ahlam Elahmady Mohamed Sarhan. Effect of Educational Program on Vulvitis Prevention among Nursing Students. American Journal of Nursing Science . Vol. 7, No. 6, 2018, pp. 254-267. doi: 10.11648/j.ajns.20180706.19 Received : November 7, 2018; Accepted : November 23, 2018; Published : January 2, 2019 Abstract: The aim of this study was to evaluate the effect of educational program on vulvitis prevention among nursing students Research design: A quasi-experimental design was utilized. Setting: This study was conducted at Faculty of Nursing, Benha University. Sample: convenient sample included two hundred and fifty nursing students female all enrolled in first academic years. Tools of data collection1) a structured interviewing sheet to collect data about socio-demographic characteristics, menstrual and gynecological history and knowledge of nursing students regarding vulvitis 2) reported practices assessment 3) modified likert scale for students' attitude regarding vulvitis. Results: there were general improvements regarding students' knowledge, attitude and practice regarding prevention of vulvitis with highly significant (P ≤ 0.001) difference after educational Program. The mother was the main sources of knowledge to students (60%).
    [Show full text]
  • Female Genital Tuberculosis: a Clinicopathological Study
    International Journal of Reproduction, Contraception, Obstetrics and Gynecology Desai RM et al. Int J Reprod Contracept Obstet Gynecol. 2016 Aug;5(8):2780-2783 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20162665 Research Article Female genital tuberculosis: a clinicopathological study Rathnamala M. Desai*, Sunil Kumar, Usha Brindini Department of Obstetrics and Gynaecology, Sri Dharmasthala Manjunatheshwara College of Medical Sciences and Hospital, Dharwad, Karnataka, India Received: 21 June 2016 Accepted: 09 July 2016 *Correspondence: Dr. Rathnamala M. Desai, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: The aim of this study was to describe the various clinical presentations of female genital tuberculosis and study the different methods of diagnosis and treatment. Methods: A study of all cases of female genital tuberculosis diagnosed in the last five years was done. Results: Female genital tuberculosis was diagnosed in 25 cases over a period of five years. Majority of the women (60%) were in the younger age group. Most of the women (60%) presented with infertility. Twelve (48%) women had primary infertility and 3 (12%) had secondary infertility. Nine (36%) women had secondary amenorrhea. Five (20%) women complained of abdominal pain. Thirteen (52%) women who underwent diagnostic hysterolaparoscopy as a part of evaluation for infertility were diagnosed to have genital tuberculosis.
    [Show full text]
  • Prioritization of Health Services
    PRIORITIZATION OF HEALTH SERVICES A Report to the Governor and the 74th Oregon Legislative Assembly Oregon Health Services Commission Office for Oregon Health Policy and Research Department of Administrative Services 2007 TABLE OF CONTENTS List of Figures . iii Health Services Commission and Staff . .v Acknowledgments . .vii Executive Summary . ix CHAPTER ONE: A HISTORY OF HEALTH SERVICES PRIORITIZATION UNDER THE OREGON HEALTH PLAN Enabling Legislatiion . 3 Early Prioritization Efforts . 3 Gaining Waiver Approval . 5 Impact . 6 CHAPTER TWO: PRIORITIZATION OF HEALTH SERVICES FOR 2008-09 Charge to the Health Services Commission . .. 25 Biennial Review of the Prioritized List . 26 A New Prioritization Methodology . 26 Public Input . 36 Next Steps . 36 Interim Modifications to the Prioritized List . 37 Technical Changes . 38 Advancements in Medical Technology . .42 CHAPTER THREE: CLARIFICATIONS TO THE PRIORITIZED LIST OF HEALTH SERVICES Practice Guidelines . 47 Age-Related Macular Degeneration (AMD) . 47 Chronic Anal Fissure . 48 Comfort Care . 48 Complicated Hernias . 49 Diagnostic Services Not Appearing on the Prioritized List . 49 Non-Prenatal Genetic Testing . 49 Tuberculosis Blood Test . 51 Early Childhood Mental Health . 52 Adjustment Reactions In Early Childhood . 52 Attention Deficit and Hyperactivity Disorders in Early Childhood . 53 Disruptive Behavior Disorders In Early Childhood . 54 Mental Health Problems In Early Childhood Related To Neglect Or Abuse . 54 Mood Disorders in Early Childhood . 55 Erythropoietin . 55 Mastocytosis . 56 Obesity . 56 Bariatric Surgery . 56 Non-Surgical Management of Obesity . 58 PET Scans . 58 Prenatal Screening for Down Syndrome . 59 Prophylactic Breast Removal . 59 Psoriasis . 59 Reabilitative Therapies . 60 i TABLE OF CONTENTS (Cont’d) CHAPTER THREE: CLARIFICATIONS TO THE PRIORITIZED LIST OF HEALTH SERVICES (CONT’D) Practice Guidelines (Cont’d) Sinus Surgery .
    [Show full text]
  • Pruritus Vulvae
    628 BRITISH MEDICAL JOURNAL 17 MARCH 1973 may wronglly lead to the diagnosis of primary hyperaldo- 13 Mitchell, J. D., Baxter, T. J., Blair-West, J. R., and McCredie, D. A., Archives of Disease in Childhood, 1970, 45, 376. steronism and even to the excision of the wrong endocrine 14 Voute, P. A., Meer, J. van der, and Staugaard-Kloosterziel, W., Acta Endocrinologica, 1971, 67, 197. Br Med J: first published as 10.1136/bmj.1.5854.628 on 17 March 1973. Downloaded from gland. 15 Hudson, J. B., Chobanian, A. V., and Relman, A. S., New England The opposite clinical syndrome-primary lack of renin or J'ournal of Medicine, 1957, 257, 529. 16 Jacobs, D. R., and Posner, J. B., Metabolism, 1964, 13, 522. hyporeninism-has also been recognized recently. In this 17 Vagnucci, A. H., Journal of Clinical Endocrinology and Metabolism, 1969, disease primary lack of renin (and hence of its active pro- 29, 279. 18 Perez, G., Siegel, L., and Schreiner, G. E., Annals of Internal Medicine, duct angiotension II) apparently leads to selective deficiency 1972, 76, 757. of aldosterone associated with normal cortisol production. 19 Ferrara, E., Werk, E., Hanenson, I., Privirera, P., and Kenyon, C., Clinical Research, 1970, 18, 602. The literature contains reference to some 20 cases of isolated 20 Schambelan, M., Stockigt, J. R., and Biglieri, E. G., New England J ournal of Medicine, 1972, 287, 573. analdosteronism, the first a report by J. B. Hudson and his 21 Weidman, P., et Clinical Research, 1972, 20, 249. colleagues15 in 1957. Only recently however has the primary al., deficiency been recognized as renin lack in at least some of these patients.
    [Show full text]
  • An Overview of Vulvovaginal Atrophy‑Related Sexual Dysfunction in Postmenopausal Women
    Review Article An Overview of Vulvovaginal Atrophy‑Related Sexual Dysfunction in Postmenopausal Women Tochukwu Christopher Okeke, Cyril Chukwuma Tochukwu Ezenyeaku1, Lawrence Chigbata Ikeako1, Polycarp Uchenna Agu Department of Obstetrics and Gynaecology, University of Nigeria Teaching Hospital (UNTH), Enugu, 1Anambra State University Teaching Hospital, Awka, Nigeria ABSTRACT Menopause and the climacteric period are associated with adverse risk factors for the development of vulvovaginal atrophy‑ related sexual dysfunction. Sexual dysfunction is a common problem in postmenopausal women, often underdiagnosed, inadequately treated, frequently overlooked, and most often impairing the quality of life of these women. To provide clinicians with current information on vulvovaginal atrophy‑related sexual dysfunction in postmenopausal women. This study is a literature review on vulvovaginal atrophy‑related sexual dysfunction in postmenopausal women. Relevant publications were identified through a search of PubMed and Medline, selected references, journals, and textbooks on this topic, and were included in the review. The prevalence of female sexual dysfunction increases with age. It is a common multidimensional problem for postmenopausal women that alter the physiological, biochemical, psychological, and sociocultural environment of a woman. Menopause‑related sexual dysfunction may not be reversible without therapy. Estrogen therapy is the most effective option and is the current standard of care for vulvovaginal atrophy‑related sexual dysfunction in postmenopausal women. Sexual dysfunction is a common multidimensional problem for postmenopausal women and often impairs the quality of life of these women. Estrogen preparations are the most effective treatment. Selective estrogen receptor modulators, vaginal dehydroepiandrostenedione, vaginal testosterone, and tissue‑selective estrogen complexes are promising therapies, but further studies are required to confirm their role, efficacy, and safety.
    [Show full text]
  • The Older Woman with Vulvar Itching and Burning Disclosures Old Adage
    Disclosures The Older Woman with Vulvar Mark Spitzer, MD Itching and Burning Merck: Advisory Board, Speakers Bureau Mark Spitzer, MD QiagenQiagen:: Speakers Bureau Medical Director SABK: Stock ownership Center for Colposcopy Elsevier: Book Editor Lake Success, NY Old Adage Does this story sound familiar? A 62 year old woman complaining of vulvovaginal itching and without a discharge self treatstreats with OTC miconazole.miconazole. If the only tool in your tool Two weeks later the itching has improved slightly but now chest is a hammer, pretty she is burning. She sees her doctor who records in the chart that she is soon everyyggthing begins to complaining of itching/burning and tells her that she has a look like a nail. yeast infection and gives her teraconazole cream. The cream is cooling while she is using it but the burning persists If the only diagnoses you are aware of She calls her doctor but speaks only to the receptionist. She that cause vulvar symptoms are Candida, tells the receptionist that her yeast infection is not better yet. The doctor (who is busy), never gets on the phone but Trichomonas, BV and atrophy those are instructs the receptionist to call in another prescription for teraconazole but also for thrthreeee doses of oral fluconazole the only diagnoses you will make. and to tell the patient that it is a tough infection. A month later the patient is still not feeling well. She is using cold compresses on her vulva to help her sleep at night. She makes an appointment. The doctor tests for BV.
    [Show full text]
  • Some Aspects of Œstrogenic Therapy
    Edinburgh Medical Journal February 1942 SOME ASPECTS OF (ESTROGENIC THERAPY * By W. F. T. HAULTAIN, O.B.E., M.C., B.A., M.B., F.R.C.S.Ed., F.R.C.O.G. I HAVE chosen the subject of cestrogenic therapy for this lectui e for several reasons. The first is that the discovery of the female sex hormones is of comparatively recent origin and, though no doubt there is still much to be discovered with regard to sexual physiology, the work on the natural and synthetic oestrogens has advanced rapidly, with the result that various preparations are even now of the greatest use to the clinician. Secondly, cestrogenic therapy has always been of particular interest to me, even long before I had heard of such a name, and in 1928 I 1 wrote a paper on the administration of ovarian extract for the artificial menopause, gleaned from work which I had been carrying out clinically for five years previously. Since that time I have continued my clinical observations with the various natural and synthetic oestrogenic products which have been introduced, and in this lecture I intend to include my further observations in their appropriate place. Thirdly, special work in the clinical use of has oestrogens been carried out during the last three years in my obstetrical and gynaecological wards. That being so, I intend to deal chiefly in this lecture with conditions with which I have had some clinical experience in regard to the value of oestrogens, and will do no more than refer to other conditions for which have oestrogens been recommended, of which I have no personal experience.
    [Show full text]